Table 4

Lipid and Inflammatory Measures at Week 0 and Week 16

Measurement

Week

MD Group

Mean ± SD

Within Group

Δ p-value

Week

FB Group

Mean ± SD

Within Group

Δ p-value

Between Group

Δ p-value


Total Cholesterol

0 (n = 39)

191.2 ± 39.5

p = 0.841

0 (n = 40)

187.5 ± 43.0

p = 0.687

p = 0.409

(mg/dl)

16 (n = 25)

181.3 ± 40.4

16 (n = 20)

184.9 ± 45.9

HDL

0 (n = 39)

52.0 ± 16.0

p = 0.843

0 (n = 40)

51.8 ± 18.0

p = 0.261

p = 0.62

(mg/dl)

16 (n = 25)

51.6 ± 11.3

16 (n = 20)

48.2 ± 11.3

LDL

0 (n = 39)

117.3 ± 31.8

p = 0.253

0 (n = 40)

108.8 ± 32.0

p = 0.779

p = 0.396

(mg/dl)

16 (n = 25)

111.4 ± 34.4

16 (n = 19)

110.7 ± 37.6

VLDL

0 (n = 38)

21.9 ± 13.0

p = 0.026

0 (n = 37)

27.9 ± 17.9

p = 0.01

p = 0.652

(mg/dl)

16 (n = 24)

17.5 ± 9.8

16 (n = 20)

26.1 ± 16.4

Triglycerides

0 (n = 39)

109.2 ± 63.7

p = 0.061

0 (n = 40)

134.7 ± 86.8

p = 0.009

p = 0.502

(mg/dl)

16 (n = 25)

91.8 ± 52.7

16 (n = 20)

130.4 ± 81.6

CRP

0 (n = 38)

5.7 ± 4.8

p = 0.200

0 (n = 39)

7.1 ± 9.4

p = 0.018

p = 0.45

(mg/L)

16 (n = 25)

3.6 ± 2.9

16 (n = 20)

4.3 ± 4.7

ULP

0 (n = 44)

6.1 ± 2.2

p = 0.684

0 (n = 44)

5.5 ± 1.7

p = 0.538

p = 0.973

(micromol/g creatinine)

16 (n = 27)

6.2 ± 2.2

16 (n = 20)

5.3 ± 2.4


Δ = Change from baseline to 16 weeks.

= Secondary outcomes.

Davis et al. Nutrition Journal 2010 9:11   doi:10.1186/1475-2891-9-11

Open Data